• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性与转移性睾丸生殖细胞肿瘤的关系:100 例临床病理分析。

Relationship between primary and metastatic testicular germ cell tumors: a clinicopathologic analysis of 100 cases.

机构信息

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA.

出版信息

Hum Pathol. 2013 Oct;44(10):2220-6. doi: 10.1016/j.humpath.2013.05.004. Epub 2013 Jul 12.

DOI:10.1016/j.humpath.2013.05.004
PMID:23856516
Abstract

Testicular germ cell tumors (GCTs) commonly metastasize to the retroperitoneal lymph nodes (RPLNs). We evaluated 100 cases of RPLN dissection specimens with viable GCTs after chemotherapy and compared them with their corresponding orchiectomy specimens. The mean age of patients was 28 years (range, 15-58 years). The testicular tumors consisted of mixed GCT (n = 72), teratoma (n = 18), seminoma (n = 4), embryonal carcinoma (n = 3), yolk sac tumor (n = 1), and no viable tumor (n = 2). Somatic malignant components were found in 5 cases. The metastatic tumors in the RPLNs consisted of only teratoma (n = 77) and non-teratomatous GCT (n = 23). Twenty-one patients had only teratoma in the RPLNs but not in the testis, and 10 patients had metastatic non-teratomatous GCT components that were not observed in the testis. Six patients had somatic malignant components in the RPLNs, but only one of them had such a component in the testis. Overall, 13 patients died of disease in a mean of 42 months, and the patients with only teratoma in the RPLNs had a lower mortality rate (9%) than those with non-teratomatous components (26%) (P = .044). One patient with somatic components in the primary GCT and 3 patients with somatic components in the metastases died of disease. Our study demonstrates that there is frequent discordance of histologic composition between primary and metastatic testicular GCTs. Teratoma is the most common component in treated GCTs and is usually associated with a more favorable clinical outcome than non-teratomatous GCTs. The presence of somatic components in the RPLNs metastasis indicates a poor prognosis.

摘要

睾丸生殖细胞肿瘤(GCT)通常转移至腹膜后淋巴结(RPLN)。我们评估了 100 例化疗后有存活 GCT 的 RPLN 解剖标本,并将其与相应的睾丸切除术标本进行比较。患者的平均年龄为 28 岁(范围 15-58 岁)。睾丸肿瘤包括混合 GCT(n=72)、畸胎瘤(n=18)、精原细胞瘤(n=4)、胚胎癌(n=3)、卵黄囊瘤(n=1)和无存活肿瘤(n=2)。在 5 例中发现了体细胞恶性成分。RPLN 中的转移性肿瘤仅由畸胎瘤(n=77)和非畸胎瘤 GCT(n=23)组成。21 例患者仅在 RPLN 中有畸胎瘤而在睾丸中没有,10 例患者有转移性非畸胎瘤 GCT 成分而在睾丸中没有观察到。6 例患者在 RPLN 中有体细胞恶性成分,但只有 1 例在睾丸中有这种成分。总体而言,13 例患者在平均 42 个月后死于疾病,而仅在 RPLN 中有畸胎瘤的患者死亡率(9%)低于有非畸胎瘤成分的患者(26%)(P=.044)。1 例原发性 GCT 中有体细胞成分的患者和 3 例转移性肿瘤中有体细胞成分的患者死于疾病。我们的研究表明,原发性和转移性睾丸 GCT 的组织学组成经常存在不一致。畸胎瘤是治疗后 GCT 中最常见的成分,通常与比非畸胎瘤 GCT 更好的临床结果相关。RPLN 转移中存在体细胞成分表明预后不良。

相似文献

1
Relationship between primary and metastatic testicular germ cell tumors: a clinicopathologic analysis of 100 cases.原发性与转移性睾丸生殖细胞肿瘤的关系:100 例临床病理分析。
Hum Pathol. 2013 Oct;44(10):2220-6. doi: 10.1016/j.humpath.2013.05.004. Epub 2013 Jul 12.
2
The pathology of late recurrence of testicular germ cell tumors.睾丸生殖细胞肿瘤晚期复发的病理学
Am J Surg Pathol. 2000 Feb;24(2):257-73. doi: 10.1097/00000478-200002000-00012.
3
Clinical Outcome of Retroperitoneal Lymph Node Dissection after Chemotherapy in Patients with Pure Embryonal Carcinoma in the Orchiectomy Specimen.睾丸切除标本中为单纯胚胎癌患者化疗后腹膜后淋巴结清扫术的临床结果
Urology. 2018 Apr;114:133-138. doi: 10.1016/j.urology.2018.01.014. Epub 2018 Feb 2.
4
Differentiated rhabdomyomatous tumors after chemotherapy for metastatic testicular germ-cell tumors: a clinicopathological study of seven cases mandating separation from rhabdomyosarcoma.转移性睾丸生殖细胞肿瘤化疗后发生的分化型横纹肌瘤样肿瘤:7例病例的临床病理研究,需与横纹肌肉瘤相鉴别。
Mod Pathol. 2009 Oct;22(10):1361-6. doi: 10.1038/modpathol.2009.108. Epub 2009 Jul 24.
5
Survival after an antiangiogenetic therapy and surgery in a wide spread growing teratoma originating from a testicular mixed malignant germ cell tumor.源自睾丸混合性恶性生殖细胞肿瘤的广泛生长畸胎瘤经抗血管生成治疗及手术后的生存情况。
Klin Padiatr. 2009 May-Jun;221(3):136-40. doi: 10.1055/s-0029-1220738. Epub 2009 May 12.
6
PARP expression in germ cell tumours.生殖细胞肿瘤中的 PARP 表达。
J Clin Pathol. 2013 Jul;66(7):607-12. doi: 10.1136/jclinpath-2012-201088. Epub 2013 Mar 13.
7
Pathologic findings and clinical outcomes in patients who required neoadjuvant chemotherapy before orchiectomy for testicular germ cell tumors.睾丸生殖细胞肿瘤患者在睾丸切除术前行新辅助化疗的病理发现和临床结局。
Hum Pathol. 2022 Oct;128:48-55. doi: 10.1016/j.humpath.2022.06.026. Epub 2022 Jul 9.
8
Spontaneous regression of testicular germ cell tumors: an analysis of 42 cases.睾丸生殖细胞肿瘤的自发消退:42例病例分析。
Am J Surg Pathol. 2006 Jul;30(7):858-65. doi: 10.1097/01.pas.0000209831.24230.56.
9
Retroperitoneal teratoma with somatic malignant transformation: a papillary renal cell carcinoma in a testicular germ cell tumour metastasis following platinum-based chemotherapy.腹膜后畸胎瘤伴体部恶性转化:铂类化疗后继发于睾丸生殖细胞肿瘤转移的乳头状肾细胞癌。
BMC Urol. 2013 Feb 12;13:9. doi: 10.1186/1471-2490-13-9.
10
Contemporary management of postchemotherapy testis cancer.化疗后睾丸生殖细胞肿瘤的当代治疗。
Eur Urol. 2012 Nov;62(5):867-76. doi: 10.1016/j.eururo.2012.08.014. Epub 2012 Aug 20.

引用本文的文献

1
piR-36249 and DHX36 together inhibit testicular cancer cells progression by upregulating OAS2.piR-36249与DHX36共同通过上调OAS2抑制睾丸癌细胞进展。
Noncoding RNA Res. 2023 Jan 7;8(2):174-186. doi: 10.1016/j.ncrna.2022.12.004. eCollection 2023 Jun.
2
Testicular Germ Cell Tumor Composed of Seminoma and Teratoma Metastasizing as Choriocarcinoma to the Lung Successfully Treated With Salvage Chemotherapy and Bone-Marrow Transplant: A Case Report.由精原细胞瘤和畸胎瘤组成的睾丸生殖细胞肿瘤转移为绒毛膜癌至肺部,经挽救性化疗和骨髓移植成功治疗:一例报告
Cureus. 2022 Mar 6;14(3):e22885. doi: 10.7759/cureus.22885. eCollection 2022 Mar.
3
Testicular germ cell tumor: a comprehensive review.
睾丸生殖细胞肿瘤:全面综述。
Cell Mol Life Sci. 2019 May;76(9):1713-1727. doi: 10.1007/s00018-019-03022-7. Epub 2019 Jan 22.